Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion.

Zhixiong CaiXiaoping SuLiman QiuZhenli LiXiaolou LiXiuqing DongFuqun WeiYang ZhouLiuping LuoGeng ChenHengkai ChenYingchao WangYongyi ZengXiao-Long Liu

Published in: Molecular cancer (2021)

This study was registered at Chinese Clinical Trial Registry; Registration number: ChiCTR1900020990 .

Keyphrases

clinical trial
patients undergoing
randomized controlled trial
study protocol
phase ii
free survival